Acumen Pharmaceuticals
1 follower
‌
Acumen is forging a new path towards safe and effective treatments for Alzheimer’s disease and other neurodegenerative diseases through our focus on the biology of toxic amyloid-beta oligomers.
Industries
Headquarters
Employees
Links
Org chart
Daniel O’Connell
President & CEO
Daniel O’Connell
Collapse
Russell Barton
Chief Operating Officer
Matthew Zuga
CFO & Chief Business Officer
Eric Siemers
Chief Medical Officer
Derek Meisner
Chief Legal Officer
Julie Bockenstette
EVP & Head of Human Resources
Alex Braun
VP, Head of Investor Relations
David Potter
Director, Data Management
Kasey Spencer
Director, IT
Amber Dilley
Director, Quality Assurance
Jerry Moore
Senior Advisor, Nonclinical Development
Kristen Elkins
Project Manager
